Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis

Journal of Hepatology, Supplement

Volumn 26, Issue 1, 1997, Pages 23-30

  Robin, Marie Anne ^a   Le Roy, Marie ^a   Descatoire, Véronique ^a   Pessayre, Dominique ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOCHROME P450;

ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; CYTOTOXIC T LYMPHOCYTE; ENZYMOLOGY; HUMAN; IMMUNOLOGY; METABOLISM; REVIEW; TOXIC HEPATITIS;

ANIMALS; AUTOANTIGENS; CELL MEMBRANE; CYTOCHROME P-450 ENZYME SYSTEM; HEPATITIS, TOXIC; HUMANS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030630618     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(97)82329-x     Document Type: Article

References (39)

1. Gonzales FJ, Nebert DW. Evolution of the cytochrome P-450 gene superfamily: animal-plant "warfare", molecular drive and human genetic differences in drug oxidation. Trends Genet 1990; 6: 182-6.
2. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 287-99.
3. Zimmerman HJ, Lewis JH, Ishak KG, Maddrey W. Ticrynafen-associated hepatic injury: analysis of 340 cases. Hepatology 1984; 4: 315-23.
4. Lopez Garcia MP, Dansette PM, Valadon P, Amar C, Beaune PH, Guengerich FP, Mansuy D. Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10. Eur J Biochem 1993; 213: 223-32.
5. Lecoeur S, Bonierbale E, Challin D, Gautier JC, Valadon P, Dansette PM, Catinot R, Ballet F, Mansuy D, Beaune PH. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship with the type of hepatotoxicity: Comparison with two directly hepatotoxic drugs. Chem Res Toxicol 1994; 7: 434-42.
6. Lopez-Garcia MP, Dansette P, Mansuy D. Thiophene derivatives as new mechanism-based inhibitors of cytochrome P450: inactivation of yeast-expressed human liver P450 2C9 by tienilic acid. Biochemistry 1994; 33: 166-75.
7. 2) in tienilic acid-induced hepatitis. Clin Exp Immunol 1984; 55: 561-70.
8. Beaune PH, Dansette PM, Mansuy D, Kiffel L, Finck M, Amar C, Leroux JP, Homberg JC. Human anti-endoplasmic reticulum auto-antibodies appearing in a drug induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci USA 1987; 84: 551-5.
9. Pons C, Dansette PM, Amar C, Jaouen M, Wolf R, Gregeois J, Homberg JC, Mansuy D. Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P-450 IIC11. J Pharmacol Exp Ther 1991; 259: 1328-34.
10. Bourdi M, Larrey D, Nataf J, Bernuau J, Pessayre D, Iwasaki M, Guengerich FP, Beaune PH. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450 IA2: a specific marker of dihydralazine-induced hepatitis. J Clin Invest 1990; 85: 1967-73.
11. Bourdi M, Tinel M, Beaune P, Pessayre D. Interactions of dihydralazine with cytochromes P4501A: A possible explanation for the appearance of anti-P4501A2 autoantibodies. Mol Pharmacol 1994; 45: 1287-95.
12. Bourdi M, Chen WQ, Peter RM, Martin JL, Buters JTM, Nelson SD, Pohl LR. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol 1996; 9: 1159-66.
13. Eliasson E, Kenna JG. Cytochrome P4502E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 1996; 50: 573-82.
14. Beaune P, Pessayre D, Dansette PM, Mansuy D, Manns M. Autoantibodies against cytochromes P450: Role in human diseases. Adv Pharmacol 1994; 30: 199-245.
15. De Lemos-Chiarandini C, Alvarez F, Bernard O, Homberg JC, Kreibich G. Anti-liver microsome antibody is a marker for the rat hepatocyte endoplasmic reticulum. Hepatology 1987; 7: 468-75.
16. Trautwein C, Gerken G, Löhr H, Meyer Zum Büschenfelde KH, Manns M. Lack of surface expression for the B-cell autoepitope of cytochrome P450IID6 evidenced by flow cytometry. Z Gastroenterol 1993; 31: 225-30.
17. Yamamoto AM, Mura C, De Lemos-Chiarandini C, Krishnamoorthy R, Alvarez F. Cytochrome P-450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes. Clin Exp Immunol 1993; 92: 381-90.
18. Jarasch ED, Kartenberg J, Bruder G, Fink A, Morré DJ, Franke WW. B-type cytochromes in plasma membranes isolated from rat liver, in comparison with those of endomembranes. J Cell Biol 1979; 80: 37-52.
19. Stasiecki P, Oesch F. Distribution of enzymes involved in metabolic activation of polycyclic aromatic hydrocarbons among rat liver endomembranes and plasma membranes. Eur J Cell Biol 1980; 21: 79-92.
20. Lenzi M, Bianchi FB, Cassani F, Pisi E. Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM). Clin Exp Immunol 1984; 55: 36-40.
21. Satoh H, Davies HW, Takemura T, Gillette JR, Maeda K, Pohl LR. An immunochemical approach to investigate the mechanism of halothane-induced hepatitis. Progress Drug Metab 1987; 10: 187-205.
22. Loeper J, Descatoire V, Maurice M, Beaune P, Feldmann G, Larrey D, Pessayre D. Presence of functional cytochrome P-450 on isolated rat hepatocyte plasma membrane. Hepatology 1990; 11: 850-8.
23. Wu D, Cederbaum AI. Presence of functionally active cytochrome P-450 IIE1 in the plasma membrane of rat hepatocytes. Hepatology 1992; 15: 515-24.
24. Loeper J, Descatoire V, Maurice M, Beaune P, Belghiti J, Houssin D, Ballet F, Feldmann G, Guengerich JP, Pessayre D. Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology 1993; 104: 203-16.
25. Robin MA, Maratrat M, Loeper J, Durand-Schneider AM, Tinel M, Ballet F, Beaune PH, Feldmann G, Pessayre D. Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes. Gastroenterology 1995; 108: 1110-3.
26. Robin MA, Maratrat M, Le Roy M, Le Breton FP, Bo-nierbale E, Dansette P, Ballet F, Mansuy D, Pessayre D. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera. J Clin Invest 1996; 98: 1471-80.
27. Cupers P, Veithen A, Courtoy PJ. La clathrine est-elle superflue pour l'endocytose non spécifique? Med Sci 1995; 11: 1271-8.
28. Black SD, Martin ST, Smith CA. Membrane topology of liver microsomal cytochrome P450 2B4 determined via monoclonal antibodies directed to the halt transfer signal. Biochemistry 1994; 33: 6945-51.
29. Alves C, von Dippe P, Amoui M, Levy D. Bile acid transport into hepatocyte smooth endoplasmic reticulum vesicles is mediated by microsomal epoxide hydrolase, a membrane protein exhibiting two distinct topological orientations. J Biol Chem 1993; 268: 20148-55.
30. Sakata N, Wu X, Dixon JL, Ginsberg HN. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in HepG2 cells. J Biol Chem 1993; 268: 22967-70.
31. Szczesna-Skorupa E, Ahn K, Chen CD, Doray B, Kemper B. The cytoplasmic and N-terminal transmembrane domains of cytochrome P450 contain independent signals for retention in the endoplasmic reticulum. J Biol Chem 1995; 41: 24327-32.
32. Bonierbale E. Mécanisme des hépatites immunoallergiques induites par l'acide tiénilique : activation métabolique de ce médicament et fixation covalente sur les cytochromes P4502C chez l'homme et le rat. Thèse de doctorat de l'Université Paris V, 1996.
33. Guilbert B, Dighiero G, Avrameas S. Naturally occurring antibodies against nine common antigens in normal humans. I. Detection, isolation and characterization. J Immunol 1982; 28: 2779-83.
34. Parker DC. T-cell dependent B-cell activation. Annu Rev Immunol 1993; 11: 331-60.
35. Cambier JC, Morrisson DC, Chien MM, Lehmann KR. Modeling of T-cell contact-dependent B cell activation. IL-4 and antigen receptor ligation primes quiescent B cells to mobilize calcium in response to Ia cross-linking. J Immunol 1991; 146: 2075-82.
36. Pessayre D. Role of reactive metabolites in drug-induced hepatitis. J Hepatol 1995; 23 (suppl. 1): 16-24.
37. Berson A, Renault S, Lettéron P, Robin MA, Fromenty B, Fau D, Le Bot MA, Riché C, Durand-Shneider AM, Feldmann G, Pessayre D. Uncoupling of rat and human mitochondria: a possible explanation for tacrine-induced liver dysfunction. Gastroenterology 1996; 110: 1878-90.
38. Gut J, Christen U, Huwyler J. Mechanism of halothane toxicity: Novel insights. Pharmacol Ther 1993; 58: 133-55.
39. Berson A, Fréneaux D, Larrey D, Lepage V, Douay C, Mallet C, Fromenty B, Benhamou JP, Pessayre D. Possible role of HLA in hepatotoxicity. An exploratory study with drug-induced idiosyncratic hepatitis. J Hepatol 1994; 20: 336-42.